Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach

Biological mechanisms related to cancer development can leave distinct molecular fingerprints in tumours. By leveraging multi-omics and epidemiological information, we can unveil relationships between carcinogenesis processes that would otherwise remain hidden. Our integrative analysis of DNA methyl...

Full description

Bibliographic Details
Main Authors: Cortez Cardoso Penha, R, Sexton Oates, A, Senkin, S, Park, HA, Atkins, J, Holcatova, I, Hornakova, A, Savic, S, Ognjanovic, S, Świątkowska, B, Lissowska, J, Zaridze, D, Mukeria, A, Janout, V, Chabrier, A, Cahais, V, Cuenin, C, Scelo, G, Foll, M, Herceg, Z, Brennan, P, Smith-Byrne, K, Alcala, N, Mckay, JD
Format: Journal article
Language:English
Published: Springer 2024
Description
Summary:Biological mechanisms related to cancer development can leave distinct molecular fingerprints in tumours. By leveraging multi-omics and epidemiological information, we can unveil relationships between carcinogenesis processes that would otherwise remain hidden. Our integrative analysis of DNA methylome, transcriptome, and somatic mutation profiles of kidney tumours linked ageing, epithelial–mesenchymal transition (EMT), and xenobiotic metabolism to kidney carcinogenesis. Ageing process was represented by associations with cellular mitotic clocks such as epiTOC2, SBS1, telomere length, and PBRM1 and SETD2 mutations, which ticked faster as tumours progressed. We identified a relationship between BAP1 driver mutations and the epigenetic upregulation of EMT genes (IL20RB and WT1), correlating with increased tumour immune infiltration, advanced stage, and poorer patient survival. We also observed an interaction between epigenetic silencing of the xenobiotic metabolism gene GSTP1 and tobacco use, suggesting a link to genotoxic effects and impaired xenobiotic metabolism. Our pan-cancer analysis showed these relationships in other tumour types. Our study enhances the understanding of kidney carcinogenesis and its relation to risk factors and progression, with implications for other tumour types.